CNS Pharmaceuticals Stock Price - CNSP

-0.0077 (-0.19%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
CNS Pharmaceuticals Inc CNSP NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.0523 -1.29% 4.0177 4.00 4.1646 4.07 4.07 23:59:38
Bid Price Ask Price Spread Spread % News
4.00 4.55 0.55 12.09% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
160 41,854 $ 4.06 $ 170,053 89,444 3.6501 - 5.6899
Last Trade Time Type Quantity Stock Price Currency
15:59:36 50 $ 4.01 USD

CNS Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 66.09M 16.45M -0.46 - 15.55M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 1.00 5.50%

more financials information »

CNS Pharmaceuticals News

Loading Messages....

Latest CNSP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CNSP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.334.454.004.1341,504-0.3123-7.21%
1 Month4.494.754.004.3353,619-0.4723-10.52%
3 Months4.295.493.65014.2580,854-0.2723-6.35%
6 Months4.115.68993.65014.26103,027-0.0923-2.25%
1 Year4.115.68993.65014.26103,027-0.0923-2.25%
3 Years4.115.68993.65014.26103,027-0.0923-2.25%
5 Years4.115.68993.65014.26103,027-0.0923-2.25%

CNS Pharmaceuticals Description

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.

Your Recent History
CNS Pharma..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.